Tech Company Financing Transactions
Acurex Biosciences Funding Round
Acurex Biosciences, operating out of San Carlos, received investment capital from The Michael J. Fox Foundation for Parkinson's Research.
Transaction Overview
Company Name
Announced On
5/27/2026
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
This collaboration gives us the opportunity to deepen our understanding of how this pathway may contribute to disease processes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
930 Brittan Avenue
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to rewrite the trajectory of neurodegenerative and movement disorders. We develop therapeutics that target underlying pathology, moving beyond symptom management to effectively slow or stop disease progression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lev Leytes
Chief Operating Officer
Galina Leytes
Chief Scientific Officer
William Shrader
Vice President
Sean Pintchovski
Browse more venture capital transactions:
Prev: 5/27/2026: Captive Radiology venture capital transaction
Next: 5/27/2026: Charms Interactive venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs